Antibody quantitation studies in recipients transfused with components with the highest B19V DNA concentrations
| Transfused component results . | Recipient results . | ||
|---|---|---|---|
| B19V DNA concentration, IU/mL, in donation . | B19V IgM/IgG status . | Enrollment B19V IgG titer, IU/mL . | Follow-up B19V IgG titer, IU/mL . |
| 2.9 × 1010 | −/− | 14.9 | 61.1 |
| 8.2 × 107 | −/− | 53.5 | 33.4 |
| 4.3 × 105 | −/− | 37.5 | 40.2 |
| 8.6 × 103 | +/+ | 7.6 | 15.2 |
| 1.8 × 103 | +/+ | 165.1 | 157.9 |
| Transfused component results . | Recipient results . | ||
|---|---|---|---|
| B19V DNA concentration, IU/mL, in donation . | B19V IgM/IgG status . | Enrollment B19V IgG titer, IU/mL . | Follow-up B19V IgG titer, IU/mL . |
| 2.9 × 1010 | −/− | 14.9 | 61.1 |
| 8.2 × 107 | −/− | 53.5 | 33.4 |
| 4.3 × 105 | −/− | 37.5 | 40.2 |
| 8.6 × 103 | +/+ | 7.6 | 15.2 |
| 1.8 × 103 | +/+ | 165.1 | 157.9 |
One recipient who received a component with a DNA concentration of 3.1 × 103 IU/mL (which was also positive for B19V IgM and IgG) was not included in this table because the enrollment and follow-up specimens were both B19V IgG negative.